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ance in HF, we analyzed Tc-MIBI washout of the heart and leg mus-
cles along with other clinical and cardiopulmonary exercise (CPX)
parameters.
We studied 45 consecutive hospitalized patients with CHF treated
for acute decompensation. CHFwas deﬁned by the Framingham criteria.
Written informed consent was obtained from all patients, and the study
conformed to the ethical guidelines of the 1975 Declaration of Helsinki
and was approved by the Institutional Review Board of Kitano Hospital.
The exclusion criteria consisted of Killip class IV HF at the time of the
study, acute myocardial infarction, and no consent. EchocardiographicHeart failure (HF) is a chronic and devastating illness becoming
an increasingly important burden on the health care system. Reduced
exercise tolerance is an independent predictor of hospital readmission
andmortality in patients with HF [1], and is thought to be a therapeutic
target [2]. Although central factors such as ejection fraction (EF) or car-
diac output do play a role, peripheral factors which include reduced
skeletal muscle, an alteration in ﬁber type to one with less oxidative
properties, and decreased ATP production, are mainly responsible for
the reduction in exercise capacity [3]. From theseﬁndings,mitochondri-
al function is thought to be an important factor in the skeletal muscle in
HF patients.
We recently reported that the retention of Technetium-99m
sestamibi (99mTc-MIBI) correlated inversely with mitochondrial func-
tion in vivo and ex vivo in various organs [4]. 99mTc-MIBI is a lipophilic
cation used for the clinical diagnosis of coronary artery disease. 99mTc-
MIBI is transported to the myocardium via coronary blood ﬂow,
where it is rapidly incorporated into myocardial cells by diffusion, and
binds to mitochondria [4,5]. In clinical settings, the MIBI washout rate
increased if mitochondrial dysfunction was present in HF patients [6].
Moreover, we and other groups demonstrated that mitochondrial func-
tional assessment by 99mTc-MIBI was not organ-speciﬁc including the
skeletal muscle [4,7,8].ability and freedom from bias of
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data, levels of brain natriuretic peptide (BNP), the estimated glomerular
ﬁltration rate, C-reactive protein levels, and medical history were ana-
lyzed. A dose of 740 MBq (20 mCi) of 99mTc-MIBI was administered in-
travenously under resting conditions after an overnight fast. Planar
images followed by single photon emission computed tomography im-
ages were obtained 20min and 3 h after the injection for the calculation
of the washout rate (Supplementary materials) [6].
All data are expressed as the mean ± standard deviation (SD).
Differences between groups were compared using the Mann–Whitney
U-test. The correlation analysis was carried out using the Pearson's
product-moment. A multiple general linear model in Poisson distribu-
tion by the likelihood-ratio chi-square test was usedwhen the determi-
nants of parameters were analyzed. In all tests, a value of p b 0.05 was
considered signiﬁcant.
Patient characteristics were as follows: 62% were male; 37% had
dilated cardiomyopathy; 55% had hypertension; 24% had diabetes; the
mean age was 68 years; the mean EF was 41%; the mean BNP level
was 370 pg/mL; and the mean washout rate of the heart and the leg
muscles was 46% and 30%, respectively. See details in Supplementary
Table 1.
Fig. 1A and B showmultiple scatter plots and correlation coefﬁcient,
respectively, of the variables. The 99mTc-MIBI washout of the heart and
BNP and the washout of the heart and leg muscles were focused in
Fig. 1C and D, respectively. A higher washout rate represents mitochon-
drial dysfunction. The washout rate of the heart inversely correlated to
BNP level increase (Fig. 1C). 99mTc-MIBI washout rate of the heart posi-
tively correlated with the washout rate of the leg muscles (Fig. 1D), but
not with left ventricular EF (Fig. 1A, pink circle). In multivariate regres-
sion analyses (Supplementary Table 2), the 99mTc-MIBI washout rate of
the leg muscle and BNP levels were the factors that determined the
washout rate of the heart.e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Association between theMIBIwashout rate of the heart and legmuscles (A).Multiple scatter plots of the variables. A red circle focused in panel C. A purple circle focused in panel D.
A pink circle indicated the relationship between 99mTc-MIBI washout rate of the heart and left ventricular ejection fraction. (B) Pearson's correlation coefﬁcient. (C) BNP levels and
99mTc-MIBI washout rate of the heart and (D) 99mTc-MIBI washout rate of the heart and leg muscles. Line, linear correlation with standard deviation.
Fig. 2. Association between the CPX parameters and the MIBI washout rate of the heart and leg muscles (A). Multiple scatter plots of the variables. (B) Peak oxygen consumption and
99mTc-MIBI washout rate of the leg muscles. Line, linear correlation with standard deviation.
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Patients who underwent CPX were younger, but the other parameters
were not signiﬁcantly different from those who did not undergo CPX
(Supplementary Fig. 2 and Table 3). PeakVO2 was negatively correlated
with the 99mTc-MIBI washout of the leg muscles and weakly positively
correlated with the length of the circumﬂex of the thigh (Fig. 2A).
Fig. 2B shows the relationship between peak oxygen consumption and
99mTc-MIBI washout of the leg muscles. Determinants of peak oxygen
consumption in the subgroup were the 99mTc-MIBI washout of the leg
and EF. Multi-collinearity was observed between the 99mTc-MIBI wash-
out of the heart and leg muscles and the length of the circumﬂex of the
thigh (Supplementary Table 4).
The factors linking the heart and the leg muscle are currently
unknown. Mechanisms involving sympathetic neural activation; cellular
metabolism in the cardiac and skeletal muscles; inter-organ relationships
such as anemia, chronic kidney disease, liver congestion, and depression;
and inﬂammatory cytokinesmay contribute to the linkage betweenmito-
chondrial function of the heart and peripheral muscles in HF patients [9].
Brain-derived neurotrophic factor is involved in depression and is de-
creased in HF patients. It regulates skeletal muscle energy metabolism
and is one of the linking factor candidates [10].
Muscle mass (i.e., circumﬂex of the thigh), in addition to the mito-
chondrial function of the legs, is thedeciding factor for exercise capacity.
In fact, a reduction in mitochondrial function and the inability to utilize
oxygen delivered, i.e. low peripheral O2 extraction may contribute to
the reduction in oxidative capacity. Thus, possible targets for exercise
interventions to improve exercise intolerance in HF are not only the
muscle's mass but also the quality of the skeletal muscle [3].
There are several limitations. First, CPX was not done in all patients,
and there were no CPX values in healthy controls. Second, we could not
assess other markers of mitochondrial function or morphology of the
heart and skeletal muscles as such analysis requires biopsy samples,
which is beyond the scope of the study.
In summary, we demonstrated a clear correlation of mitochondrial
function between the heart and skeletal muscles and biomarkers of
HF. Our results indicate that mitochondrial function of the leg muscle,
along with the muscle volume, may limit exercise capacity in patients
with CHF.
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